Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MERRISSA GALLEGOS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1235689498
CMS profile
10626097
Location
DACULA, GA

General Payments · PY2021–2024

$1,533.53

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$336.44

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $336.44 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $548.67 21
PY2022 $422.89 15
PY2023 $225.53 11
PY2024 $336.44 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $16.10 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105773228 CMS
AstraZeneca Pharmaceuticals LP $24.83 09/26/2024 Food and Beverage Undisputed 01/23/2026 1105816047 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.31 03/14/2024 Food and Beverage Undisputed 01/23/2026 1117928510 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.92 08/22/2024 Food and Beverage Undisputed 01/23/2026 1117928508 CMS
Exact Sciences Corporation $17.15 04/19/2024 Food and Beverage Undisputed 01/23/2026 1114666540 CMS
GlaxoSmithKline, LLC. $16.17 11/07/2024 Food and Beverage Undisputed 01/23/2026 1116647411 CMS
Lilly USA, LLC $17.29 02/29/2024 Food and Beverage Undisputed 01/23/2026 1135820377 CMS
Lilly USA, LLC $25.05 05/16/2024 Food and Beverage Undisputed 01/23/2026 1135791320 CMS
Lilly USA, LLC $20.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 1135758278 CMS
Lilly USA, LLC $31.16 07/11/2024 Food and Beverage Undisputed 01/23/2026 1135791322 CMS
Merck Sharp & Dohme LLC $13.44 12/05/2024 Food and Beverage Undisputed 01/23/2026 1141766202 CMS
Novo Nordisk Inc $20.85 03/21/2024 Food and Beverage Undisputed 01/23/2026 1100276566 CMS
Novo Nordisk Inc $14.76 05/09/2024 Food and Beverage Undisputed 01/23/2026 1100556789 CMS
PFIZER INC. $20.74 02/08/2024 Food and Beverage Undisputed 01/23/2026 1131044719 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.74 04/29/2024 Food and Beverage Undisputed 01/23/2026 1153728826 CMS
Verity Pharmaceuticals Inc. $30.40 11/14/2024 Food and Beverage Undisputed 01/23/2026 1080615197 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.